Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rifampin vs. rifapentine: what is the preferred rifamycin for tuberculosis?
Alfarisi O, Alghamdi WA, Al-Shaer MH, Dooley KE, Peloquin CA. Alfarisi O, et al. Among authors: alghamdi wa. Expert Rev Clin Pharmacol. 2017 Oct;10(10):1027-1036. doi: 10.1080/17512433.2017.1366311. Epub 2017 Aug 18. Expert Rev Clin Pharmacol. 2017. PMID: 28803492 Review.
Protein Binding of First-Line Antituberculosis Drugs.
Alghamdi WA, Al-Shaer MH, Peloquin CA. Alghamdi WA, et al. Antimicrob Agents Chemother. 2018 Jun 26;62(7):e00641-18. doi: 10.1128/AAC.00641-18. Print 2018 Jul. Antimicrob Agents Chemother. 2018. PMID: 29735566 Free PMC article.
Perspectives for personalized therapy for patients with multidrug-resistant tuberculosis.
Lange C, Alghamdi WA, Al-Shaer MH, Brighenti S, Diacon AH, DiNardo AR, Grobbel HP, Gröschel MI, von Groote-Bidlingmaier F, Hauptmann M, Heyckendorf J, Köhler N, Kohl TA, Merker M, Niemann S, Peloquin CA, Reimann M, Schaible UE, Schaub D, Schleusener V, Thye T, Schön T. Lange C, et al. Among authors: alghamdi wa. J Intern Med. 2018 May 28. doi: 10.1111/joim.12780. Online ahead of print. J Intern Med. 2018. PMID: 29806961 Free article.
Effect of Rifampin-Isoniazid-Containing Antituberculosis Therapy on Efavirenz Pharmacokinetics in HIV-Infected Children 3 to 14 Years Old.
Kwara A, Yang H, Antwi S, Enimil A, Gillani FS, Dompreh A, Ortsin A, Opoku T, Bosomtwe D, Sarfo A, Wiesner L, Norman J, Alghamdi WA, Langaee T, Peloquin CA, Court MH, Greenblatt DJ. Kwara A, et al. Among authors: alghamdi wa. Antimicrob Agents Chemother. 2018 Dec 21;63(1):e01657-18. doi: 10.1128/AAC.01657-18. Print 2019 Jan. Antimicrob Agents Chemother. 2018. PMID: 30397066 Free PMC article.
Cycloserine Population Pharmacokinetics and Pharmacodynamics in Patients with Tuberculosis.
Alghamdi WA, Alsultan A, Al-Shaer MH, An G, Ahmed S, Alkabab Y, Banu S, Barbakadze K, Houpt E, Kipiani M, Mikiashvili L, Schmidt S, Heysell SK, Kempker RR, Cegielski JP, Peloquin CA. Alghamdi WA, et al. Antimicrob Agents Chemother. 2019 Apr 25;63(5):e00055-19. doi: 10.1128/AAC.00055-19. Print 2019 May. Antimicrob Agents Chemother. 2019. PMID: 30858211 Free PMC article.
Fluoroquinolones in Drug-Resistant Tuberculosis: Culture Conversion and Pharmacokinetic/Pharmacodynamic Target Attainment To Guide Dose Selection.
Al-Shaer MH, Alghamdi WA, Alsultan A, An G, Ahmed S, Alkabab Y, Banu S, Barbakadze K, Houpt E, Kipiani M, Mikiashvili L, Cegielski JP, Kempker RR, Heysell SK, Peloquin CA. Al-Shaer MH, et al. Among authors: alghamdi wa. Antimicrob Agents Chemother. 2019 Jun 24;63(7):e00279-19. doi: 10.1128/AAC.00279-19. Print 2019 Jul. Antimicrob Agents Chemother. 2019. PMID: 31061152 Free PMC article.
Effect of First-Line Antituberculosis Therapy on Nevirapine Pharmacokinetics in Children Younger than Three Years Old.
Enimil A, Antwi S, Yang H, Dompreh A, Alghamdi WA, Gillani FS, Orstin A, Bosomtwe D, Opoku T, Norman J, Wiesner L, Langaee T, Peloquin CA, Court MH, Greenblatt DJ, Kwara A. Enimil A, et al. Among authors: alghamdi wa. Antimicrob Agents Chemother. 2019 Sep 23;63(10):e00839-19. doi: 10.1128/AAC.00839-19. Print 2019 Oct. Antimicrob Agents Chemother. 2019. PMID: 31332062 Free PMC article.
50 results